442 related articles for article (PubMed ID: 11898040)
1. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
2. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
3. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
5. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Funabiki T; Jinno O; Sakurai Y; Hasegawa S; Imazu H; Ochiai M
J Hepatobiliary Pancreat Surg; 1999; 6(3):286-93. PubMed ID: 10526065
[TBL] [Abstract][Full Text] [Related]
7. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
9. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
10. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review).
Tsuchida A; Itoi T; Aoki T; Koyanagi Y
Oncol Rep; 2003; 10(6):1693-9. PubMed ID: 14534681
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development.
Seki M; Yanagisawa A; Ninomiya E; Ninomiya Y; Ohta H; Saiura A; Yamamoto J; Yamaguchi T; Aruga A; Yamada K; Takano K; Fujita R; Ikeda M; Sasaki K; Kato Y
J Hepatobiliary Pancreat Surg; 2005; 12(3):254-62. PubMed ID: 15995816
[TBL] [Abstract][Full Text] [Related]
13. Pancreatobiliary disorders associated with pancreaticobiliary maljunction.
Kamisawa T; Honda G; Kurata M; Tokura M; Tsuruta K
Dig Surg; 2010; 27(2):100-4. PubMed ID: 20551651
[TBL] [Abstract][Full Text] [Related]
14. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
15. DPC-4 (Smad-4) and K-ras gene mutations in biliary tract epithelium in children with anomalous pancreaticobiliary ductal union.
Shimotake T; Aoi S; Tomiyama H; Iwai N
J Pediatr Surg; 2003 May; 38(5):694-7. PubMed ID: 12720172
[TBL] [Abstract][Full Text] [Related]
16. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
17. Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux.
Itoi T; Tsuchida A; Itokawa F; Sofuni A; Kurihara T; Tsuchiya T; Moriyasu F; Kasuya K; Serizawa H
Int J Mol Med; 2005 Mar; 15(3):425-30. PubMed ID: 15702232
[TBL] [Abstract][Full Text] [Related]
18. Relationship between types of common channel and development of biliary tract cancer in pancreaticobiliary maljunction.
Hara H; Morita S; Sako S; Dohi T; Otani M; Iwamoto M; Inoue H; Tanigawa N
Hepatogastroenterology; 2002; 49(44):322-5. PubMed ID: 11995442
[TBL] [Abstract][Full Text] [Related]
19. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.
Rashid A; Ueki T; Gao YT; Houlihan PS; Wallace C; Wang BS; Shen MC; Deng J; Hsing AW
Clin Cancer Res; 2002 Oct; 8(10):3156-63. PubMed ID: 12374683
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]